Gliomas represent over 30% of all CNS tumors and over 80% of malignant brain tumors. In this webinar, Dr. Carolyn Marks Research Scientist, Protein Technologies, R&D, at Atlas antibodies, discusses recent advances in our understanding of gliomas, starting from a short history and evolution of glioma classification, the diagnostic and therapeutic challenges, and the molecular markers useful for tissue and cell analysis.